Crossmark

Real-life impact of anti-IL5 therapy on exacerbation types in patients with obstructive lung disease

Crossref DOI link: https://doi.org/10.1136/bmjresp-2025-003413

Published Online: 2025-10-22

Published Print: 2025-10

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Vanfleteren, Lowie E G W

Vauterin, Delphine https://orcid.org/0000-0002-8932-476X
Lahousse, Lies https://orcid.org/0000-0002-3494-4363
License Information

License valid from 2025-10-22